The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally...
The FDA approves the first generic versions of Zyprexa tablets and Zyprexa Zydus orally disintegrating tablets to treat schizophrenia and bipolar disorder. The drugs will be jointly manufactured and distributed by Dr. Reddy's Labs (RDY +1%), Teva Pharmaceuticals (TEVA +0.9%) and Par Pharmaceuticals (PRX +1.9%).
From other sites
at Investor's Business Daily (Jan 8, 2015)
at CNBC.com (Nov 6, 2014)
at MarketWatch.com (Oct 17, 2014)
at CNBC.com (Jan 16, 2014)
at MarketWatch.com (Jan 7, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs